Novartis | NOVN - Current Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Novartis

Novartis reported $32.11B in Current Assets for its fiscal quarter ending in March of 2023.


Current Assets Change
Alcon AG ALC:SW USD 5.33B 138M
Almirall SA ALM:SM EUR 552.72M 11.07M
Amgen AMGN:US USD 44.7B 22.52B
Artemis Alpha ATS:LN GBP 4.91M 719K
AstraZeneca AZN:LN USD 22.27B 327M
Bayer BAYN:GR EUR 39.62B 1.86B
Biogen BIIB:US USD 9.76B 28.7M
Eli Lilly LLY:US USD 20.81B 2.78B
Fresenius FRE:GR EUR 19.1B 823M
Galapagos GLPG:NA EUR 4.16B 81.56M
Genmab GEN:DC DKK 28.23B 146M
Gilead Sciences GILD:US USD 14.37B 855M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
Hikma Pharmaceutical HIK:LN USD 2B 145M
J&J JNJ:US USD 64.39B 9.09B
Lonza Group LONN:SW CHF 5.72B 13M
Merck MRK:GR EUR 12.95B 750M
Novartis NOVN:VX USD 32.11B 4.8B
Novartis NVS:US USD 32.11B 4.8B
Orion ORNBV:FH EUR 664.8M 213.9M
Recordati REC:IM EUR 1.19B 17.59M
Regeneron Pharmaceuticals REGN:US USD 16.91B 1.03B
Roche Holding ROG:VX 33.82B 3.5B
UCB UCB:BB 3.3B 45M